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Abstract
Background: Internalin A (InlA) is a critical virulence factor which mediates the initiation of Listeria monocytogenes
infection by the oral route in permissive hosts. The interaction of InlA with the host cell ligand E-cadherin
efficiently stimulates L. monocytogenes entry into human enterocytes, but has only a limited interaction with
murine cells.
Results: We have created a surface display library of randomly mutated InlA in a non-invasive heterologous host
Lactococcus lactis in order to create and screen novel variants of this invasion factor. After sequential passage
through a murine cell line (CT-26), multiple clones with enhanced invasion characteristics were identified.
Competitive index experiments were conducted in mice using selected mutations introduced into L.
monocytogenes EGD-e background. A novel single amino acid change was identified which enhanced virulence by
the oral route in the murine model and will form the basis of further engineering approaches. As a control a
previously described EGD-InlA
m murinized strain was also re-created as part of this study with minor modifications
and designated EGD-e InlA
m*. The strain was created using a procedure that minimizes the likelihood of secondary
mutations and incorporates Listeria-optimized codons encoding the altered amino acids. L. monocytogenes EGD-e
InlA
m* yielded consistently higher level murine infections by the oral route when compared to EGD-e, but did not
display the two-fold increased invasion into a human cell line that was previously described for the EGD-InlA
m
strain.
Conclusions: We have used both site-directed mutagenesis and directed evolution to create variants of InlA which
may inform future structure-function analyses of this protein. During the course of the study we engineered a
murinized strain of L. monocytogenes EGD-e which shows reproducibly higher infectivity in the intragastric murine
infection model than the wild type, but does not display enhanced entry into human cells as previously observed.
This murinized L. monocytogenes strain will provide a useful tool for the analysis of the gastrointestinal phase of
listeriosis.
Background
Internalin A (InlA) is a sortase achored, cell wall protein
and a critical factor in the pathogenesis of the food-
borne Gram-positive pathogen Listeria monocytogenes.
InlA stimulates L. monocytogenes entry into normally
non-phagocytic intestinal enterocytes [1]. The protein is
800 amino acids (aa) in length and composed of seven
distinct domains (Figure 1a); (i), 1-35 aa: a consensus N-
terminal signal sequence (SS); (ii), 35-78 aa: forms a cap
at the N-terminus tip of mature protein (C); (iii), 79-407
aa: 15 Leucine rich repeats (LRR) with 14 containing 22
aa (repeat 6 contains 21 aa) (shaded grey); (iv), 415-495
aa: an inter-repeat domain (IR); (v), 518-706 aa: three b-
repeat domains, which may serve as a stalk to project
the sickle shaped LRR out from the cell surface (b1, b2
and b3); and (vi), 767-771 aa: a sortase cleavage site
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771-800 aa: a membrane targeting sequence (TM)[2].
Domain (iii) containing the LRR’s of InlA is sufficient to
stimulate enterocyte uptake [3,4]. The enterocyte ligand
for InlA was identified as E-cadherin (CDH1) [5], which
is required by host cells for the formation of tight junc-
tions and to promote cellular polarization, communica-
tion and differentiation [6]. The localization of CDH1
on the basolateral face of differentiated cells suggested
that invasion was a secondary event, occurring after
non-specific uptake by M cells [5]. Oral infection studies
using rats [7] and mice [8] provided support for this
hypothesis. However, oral infections resulted in the
invasion of enterocytes in a guinea pig model [9].
Human colonic Caco-2 enterocyte cells are also directly
permissive to infection in vitro [9,10]. These seemingly
anomalous results are due to the reduced affinity of
murine CDH1 (mCDH1) for InlA. The reduced affinity
was localized to amino acid 16 which is a proline in gui-
nea pig and human CDH1 (hCDH1) but in rats and
mice a glutamic acid is present [11]. This discovery led
to the development and application of a transgenic
mouse model expressing both human and murine
CDH1 within intestinal enterocytes, which conclusively
demonstrated the role of InlA in the pathogenesis of
orally acquired L. monocytogenes [ 1 2 ] .I na ne l e g a n t
study, the site of enterocyte cell extrusion at the tips of
intestinal villi was identified as a mechanism for expos-
ing CDH1 on the apical surface at multicellular junc-
tions [13]. More recently, a transgenic mouse strain that
ubiquitously expresses human E-cadherin has been
developed to demonstrate a role for InlA (and InlB) in
fetoplacental listeriosis [14].
The crystal structure of InlA in complex with hCDH1
demonstrated the structural importance of proline 16
for the interaction [15]. In silico analysis confirmed that
the reduced affinity of InlA for mCDH1was essentially
due to the steric hindrance imposed by the bulky gluta-
mic acid at aa 16, which therefore could not interact
with the hydrophobic pocket (between LRR’s5 ,6a n d7
of InlA) created by the removal of one amino acid from
LRR 6 [15]. Overall the crystal structure identified 28
residues of hCDH1 that interact with the residues across
the LRR region. Structural data and the invasion results
from previous research [3,4] have confirmed the essen-
tial nature of the LRR’s in the InlA::CDH1 interaction.
Small animal model of listeriosis have a number of
significant limitations. Even though rabbits and guinea
pigs possess a permissive CDH1, they have recently
been shown to be resistant to systemic infection due to
a species specificity observed in the InlB/host interaction
[16]. InlB is required for efficient hepatocyte/endothelial
cell invasion in the mouse model and in certain human
cell lines. A novel approach to address the lack of
appropriate animal models focused on the ‘murinization’
of L. monocytogenes rather than the ‘humanization’ of
mice [17]. Rational protein design based on the struc-
tural data of the InlA/hCDH1 complex, identified two
mutations in InlA (Ser192Asn and Tyr369Ser) that dra-
matically increased the affinity for both hCDH1 and
mCDH1. This allowed the development of a variant of
L. monocytogenes EGD-e (EGD-InlA
m)c a p a b l eo fe s t a b -
lishing systemic infections in C57BL/6J mice after oral
inoculation [17]. However, the strain also exhibited a 2-
fold increase in adhesion and consequently invasion into
human cells, suggesting that the alteration in tropism
towards mice also could enhance the virulence towards
humans.
To address any remaining concerns regarding human
virulence of murinized L. monocytogenes,w ec o n d u c t e d
random mutagenesis of InlA combined with surface dis-
play on a non-invasive, Gram-positive, Lactococcus lactis
to identify mutations that improve the entry into a colo-
nic murine cell line. Using the CT-26 cells as a selection
tool, multiple positive mutations in independent clones
were identified with an enrichment in the InlA/hCDH1
interacting residues. The inlA genes from 4 L. lactis
clones were separately recombined into the inlA chro-
mosomal locus in EGD-eΔinlA generating EGD-e A to
D. Also, a version of EGD-InlA
m [17] was created in
order to permit comparison with our newly generated
Figure 1 Nisin inducibe InlA plasmid constructs and the
expression of InlA
WT on the surface of L. lactis. A. Lactococcal
nisin inducible plasmid pNZB with the entire (i) inlA
WT gene from
EGD-e cloned upstream of the nisin inducible nisA promoter (P).
The labels for the InlA domains are described in the introduction
text. The naturally occuring BglII/BstXI restriction sites within the inlA
gene encompass the entire LRR required for the interaction with E-
cadherin. These two sites were used for the cloning of the (ii) the
murinized version of inlA (inlA
m*) with the amino acid changes as
described by Wollert et al. [17] (created by site directed
mutagenesis) and (iii) four randomly mutated banks of inlA
generated by error prone PCR. B. A lysozyme cell wall extract was
isolated from L. lactis InlA
WT grown under the conditions used for
invasion assay. Exponential phase cells (OD = 0.6) were cultured for
1 h in the presence (+) or absence (-) of nisin (approx 10 ng/ul).
Proteins were run on 10% SDS-PAGE and either stained with
coomassie blue or blotted and detected with a InlA monoclonal
antibody [23].
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employed by Wollert et al. [17] we utilised preferred Lis-
teria codons for the mutated 192Asn and 369Ser and
designated the strain; EGD-e InlA
m*. Strains were com-
peted against EGD-e InlA
m* in oral murine competitive
index assays [18]. A novel aa mutation was identified
which enhanced InlA/mCHD1 interaction compared to
EGD-e. In agreement with earlier studies [17] the adher-
ence/invasion into Caco-2 cells and virulence by murine
intravenous infection of the codon-optimized EGD-e
InlA
m* strain was indistinguishable from EGD-e, while
EGD-e InlA
m* alone exhibited highly reproducible mur-
ine oral infections.
Methods
Bacterial and Cell Culture
Bacterial strains, plasmids and oligonucleotides are
described in Table 1. For the routine propagation of
L. lactis MG1363 derivative NZ9000, cells were grown
statically at 30°C in M17 (Oxiod) broth containing 0.5%
w/v filter sterilized glucose (GM17). L. monocytogenes
were cultivated in BHI (Oxiod) and Escherichia coli
grown in LB at 37°C with shaking at 200 rpm. For
growth on agar, respective broths were solidified with
1.5% (w/v) agar (Merck). For blue/white screening in L.
monocytogenes, X-gal (Merck) was incorporated into
BHI agar at 100 μg/ml. Antibiotics were added when
required: erythromycin E. coli - 250 μg/ml, L. monocyto-
genes -5μg/ml and chloramphenicol L. lactis -5μg/ml.
Plasmids were isolated from NZ9000 after overnight
growth in 10 ml of GM17. To lyse, the pellet was resus-
pended in 500 μl of P1 buffer (see Qiagen manual) con-
taining 30 μg of lysozyme and incubated for 30 min at
37°C. The lysate was processed as described in the
Qiaprep spin miniprep kit (Qiagen). A nisin filtrate for
PnisA induction was isolated from the supernatant of an
overnight L. lactis culture of NZ9700 (filter sterilized
through 0.22μM low protein binding filters - Millipore), ali-
quots frozen at -20°C. For all InlA induction experiments,
overnight L. lactis NZ9000 cultures (containing pNZ8048
plasmids) were diluted 1:20 in 10 ml of fresh GM17 and
grown to an OD600 nm of 0.5 (approximately 2 h). The
expression of inlA was induced with 10 μl of nisin and
grown for a further hour to an OD = 1.0 (5×10
8 cfu/ml).
The murine (CT-26) and human (Caco-2) colonic epithe-
lial cell lines were routinely cultured at 37°C in 5% CO2.
Media was composed of DMEM glutamax, 10% FBS, Pen/
Strep and 1% non essential amino acids with all cell culture
media purchased from Gibco. Oligonucelotides were pur-
chased from Eurofins MWG Operon.
Production of electrocompetent Lactococcus lactis
The protocol of Holo and Nes [19] was adapted for the
transformation of L. lactis MG1363 derivative NZ9000.
A GM17 overnight culture of NZ9000 was diluted
1:100 into 5 ml of GM17 containing 500 mM sucrose
and 2.5% glycine (GS-GM17). This culture was inocu-
l a t e di n t o5 0m lo ff r e s hG S - G M 1 7a n dg r o w no v e r -
night. The 50 ml culture was inoculated into 400 ml of
fresh GS-GM17, grown to OD600 of 0.3 and cells were
subsequently harvested by centrifugation at 4,000 × g
for 20 min at 4°C. The pellet was resuspended in 200
ml of ice cold SGB (500 mM sucrose and 10% (w/v)
glucose - filter sterilized), centrifuged, resuspended in
100 ml SGB and left on ice for 15 min. The cells were
centrifuged, resuspended in 50 ml SGB and left on ice
for 15 min before a final centrifugation and re-suspen-
sion with 2 ml SGB. Cells were frozen at -80°C in 40
μl aliquots. To electroporate, cells were thawed on ice,
mixed with 4 ul of pellet paint (Novagen) precipitated
DNA and transferred to a 1 mm electroporation cuv-
ette (Biorad). Cells were pulsed at 20 kV/cm, 200 Ω
and 25 μF, regenerated in 1 ml GM17 containing 2
mM CaCl2/20 mM MgCl2 for 1.5 h and then plated
onto GM17 agar containing 5 μg/ml chloramphenicol.
An efficiency of 1 × 10
7 cfu/μg was routinely obtained
with pNZ8048.
Cloning of InlA into pNZB
The unique BglII site up stream of the nisA promoter in
pNZ8048 was removed by linearization of the vector
with BglII and ends blunted with T4 DNA polymerase.
The vector was religated to generate pNZB. The inlA
gene was PCR amplified (primers IM194 and IM188) as
described previously [20], digested with NcoI/PstIa n d
ligated into the complementary digested pNZB. Liga-
tions were directly electroporated into NZ9000 as
described above and the sequence of the inlA gene was
verified by DNA sequencing.
QuikChange mutagenesis in L. lactis
Primers for site directed mutagenesis (SDM) (Table 1)
were designed according to the Quikchange SDM man-
ual (Stratagene). All plasmid template isolated from
NZ9000 strains was methylated with Dam methylase fol-
lowing manufacturer recommendations (New England
Biolabs). The PCR thermocycling conditions were con-
ducted as described previously [21]. Separate 50 μl KOD
hotstart high fidelity polymerase PCR reactions were
preformed with each primer for 10 cycles and an exten-
sion time of 5 min 30 sec. After 10 cycles the reactions
were combined and continued for an additional 18
cycles. Amplimers were column purified (Qiaquick PCR
purification kit, Qiagen) and digested overnight with
DpnI (Roche). Digests were pellet paint precipitated and
the half of the digest directly electroporated into
NZ9000. Between 200 and 1000 colonies were obtained
per transformation. The protocol was repeated to
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Name Description Source
Bacterial strains
EC10B E. coli DH10B derivative, with repA integrated into the glgB gene. Kan
r. [20]
NZ9000 Nisin responsive L. lactis MG1363 derivative, with nisRK integrated into the pepN gene. [26]
EGD-e L. monocytogenes 1/2a strain. Genome sequenced. Obtained from Werner Goebel. [39]
EGD-eΔinlA EGD-e with the E-cadherin interacting region of InlA deleted (amino acids 80 to 506) [20]
EGD-eΔinlA::
pIMK2inlA
EGD-e ΔinlA with InlA over expressed from the Phelp promoter integrated at tRNA
Arg locus, Kan
r [20]
EGD-e InlA
m* EGD-e with inlA residues S192N and Y369 S modified in the chromosome. This study
EGD-e A EGD-eΔinlA with inlA locus recreated containing SDM change N259Y in the chromosome. This study
EGD-e B EGD-eΔinlA with inlA locus recreated containing SDM change Q190L in the chromosome. This study
EGD-e C EGD-eΔinlA with inlA the locus recreated containing SDM changes S173I, L185F and L188F in the chromosome. This study
EGD-e D EGD-eΔinlA with inlA locus recreated containing SDM changes T164A, K301I and G303E in the chromosome. This study
EGD-e InlA
m* ::
pIMC3ery
EGD-e InlA
m* with the IPTG inducible expression of erythromycin integrated in the tRNA
ARG locus, Cm
r. This study
EGD-e::pIMC3kan EGD-e with the IPTG inducible expression of kanamycin integrated in the tRNA
ARG locus, Cm
r. [18]
EGD-e A::
pIMC3kan
EGD-e A with the IPTG inducible expression of kanamycin integrated in the tRNA
ARG locus, Cm
r This study
EGD-e B::
pIMC3kan
EGD-e B with the IPTG inducible expression of kanamycin integrated in the tRNA
ARG locus, Cm
r This study
EGD-e C::
pIMC3kan
EGD-e C with the IPTG inducible expression of kanamycin integrated in the tRNA
ARG locus, Cm
r This study
EGD-e D::
pIMC3kan
EGD-e D with the IPTG inducible expression of kanamycin integrated in the tRNA
ARG locus, Cm
r This study
NZ9700 Nisin producer, progeny of NIZO B8 and MG1363 (Rif
r and Strp
r) conjugation. [26]
Plasmids
pNZB Nisin inducible plasmid with heterologous gene expressed from the nisA promoter. BglII site upstream of nisA
removed.
This study
pNZBinlA
WT Internalin A from EGD-e containing the entire gene including signal sequence. Cloned into NcoI/PstI of pNZB. This study
pNZBinlA
m* Internalin A containing S192N and Y369 S in pNZB. This study
pNZBinlA Bank-iii Error Prone PCR with low level of mutation 0-4.5 nt per kb. This study
pNZBinlA Bank-iv Error Prone PCR with medium level of mutation 4.5-9 nt per kb. This study
pNZBinlA Bank-v Error Prone PCR with high level of mutation 9-16 nt per kb. This study
pNZBinlA Bank-vi Error Prone PCR with very high level of mutation 9-16 nt per kb. This study
pORI280 RepA negative gene replacement vector, constitutive lacZ, 5.3 kb, Em
r. [40]
pORI280inlA(SDM) PCR amplified mutated inlA
m* into pORI280 as NcoI/PstI fragment. Contains wild type inlA promoter. This study
pORI280inlA(A) PCR amplified mutated inlA (from bank v clone 6 containing N259Y) into pORI280 as NcoI/PstI fragment. Contains
Wt inlA promoter.
This study
pORI280inlA(B) PCR amplified mutated inlA (from bank iii clone 3 containing Q190L) into pORI280 as NcoI/PstI fragment. Contains
Wt inlA promoter.
This study
pORI280inlA(C) PCR amplified mutated inlA (from bank v clone 6 containing S173I, L185F, L188F) into pORI280 as NcoI/PstI
fragment. Contains Wt inlA promoter.
This study
pORI280inlA(D) PCR amplified mutated inlA (from bank v clone 8 containing T164A, K301I, G303E) into pORI280 as NcoI/PstI
fragment. Contains Wt inlA promoter.
This study
pVE6007 Temperature-sensitive helper plasmid, supplies RepA in trans.C m
r. [41]
Name Oligonucleotide sequence (5’-3’)
a Restriction
site
IM194 (inlA-F) ATATCCATGGAAAAAAACGATATGTATGGTTG NcoI
IM188 (inlA-R) TTTTCTGCAGTTATTTACTAGCACGTGCTTTTTTAG PstI
IM345 (S192N
SDM-F)
CAGGTTTAACTAGTCTACAGCAATTAAATTTTGGTAATCAAGTGACAGATTTAAAACC
IM346 (S192N
SDM-R)
GGTTTTAAATCTGTCACTTGATTACCAAAATTTAATTGCTGTAGACTAGTTAAACCTG
IM349 (Y369 S
SDM-F)
CAAAGCTTCAAAGATTATTTTTCTCTAATAACAAGGTAAGTGACGTAAG
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plasmids, BglII/BstXI fragments containing the LRR
region of InlA were excised and ligated into comple-
mentary digested pNZBinlA
WT.
Isolation of cell wall proteins
Cell wall proteins were isolated from nisin induced 10
ml NZ9000+pNZBinlA
WT culture as described by pre-
viously [22], except cells were rendered as protoplasts
for 1 hr at 30°C without mutanolysin. Blotted proteins
were probed with the InlA specific monoclonal antibody
described by Hearty et al [23].
Random Bank of inlA mutants in NZ9000
The generation of a randomly mutated inlA bank
between amino acids 74 and 512 (containing the LRR)
of InlA was accomplished by error prone PCR with
Mutazyme II (Stratagene). Plasmid DNA (pNZBinlA
WT)
was used as template in the reaction (primers IM317
and IM318) and a 1.3 kb fragment amplified between
two naturally occurring restriction sites (BglII and
BstXI). From the mutagenesis reactions, four different
mutation rates by varying the amount of template used
((iii) 1000 ng (iv) 250 ng (v) 10 ng and (vi) 0.1 ng). This
equates to a sliding scale of increasing mutation fre-
quency. Each amplimer pool was digested with BglII and
BstXI and ligated into complementary digested
pNZ8048binlA. The ligations (100 ng of pNZB with 240
ng of inlA) were pellet paint precipitated and electropo-
rated into electrocompetent NZ9000 (repeated twice).
For each pool a total of 40,000 colonies were obtained
with plasmid religations accounting for 0.125% of the
total (about 50 colonies per 40,000). The colonies from
each mutation frequency were pooled and frozen at -80°
C. From each mutation frequency, 10 individual colonies
were subjected to plasmid isolation as described above
and the mutated region sequenced to access the level of
mutagenesis.
CT-26 and Caco-2 invasion assays
O v e r n i g h tc u l t u r e so fN Z 9 0 0 0c o n t a i n i n gp N Z Bo n l yo r
pNZBinlA derivatives (Figure 1a) were induced as
described above. A one ml aliquot was then pelleted at
4,000 ×gfor 5 min and resuspended in 1 ml of DMEM.
Cells were centrifuged, resuspended in fresh DMEM and
then diluted to a multiplicity of infection of 25:1. L.
monocytogenes cells were grown as described previously
prior to invasion [20]. CT-26 [24] and Caco-2 cells were
seeded at 2 × 10
4 and 1 × 10
5 cells, respectively and
grown for 4 days until confluency in 24 well plates (Fal-
con). On the day prior to use, antibiotics were removed
from the media. On the day of use, cells were washed
twice with DMEM to remove FBS. Both cell types were
invaded for 1 h at 37°C in 5% CO2,w a s h e do n c ew i t h
Dulbecco’s PBS (Sigma) and then overlayed with DMEM
containing 10 (Caco-2) or 100 μg/ml (CT-26) gentamicin
for 1 h. Monolayers were washed a further three times
with PBS to remove residual antibiotic and then lysed
with 1 ml of ice cold sterile water. Bacterial cells were
enumerated by serial dilution in PBS and plated on
GM17 agar containing 5 μg/ml chloramphenicol. The
remaining lysate from error prone PCR pools were inocu-
lated into GM17 containing 5 μg/ml chloramphenicol,
grown overnight, stocked at -80°C with the protocol
repeated for seven passages through CT-26 cells. EGD-e
derivatives were plated onto BHI agar.
Internalin A chromosomal mutagenesis in L.
monocytogenes
A 2 kb fragment was PCR amplified (primers IM467 and
IM490) from the appropriate mutated pNZ8048binlA
plasmid, with primer design incorporating the first 16 nt
upstream of the inlA GTG start codon. The amplimers
were digested with NcoI/PstI, ligated into complementary
digested pORI280 and transformed into E. coli strain
EC10B (Table 1). The plasmids pORI280 and pVE6007
we co-transformed into EGD-eΔinlA and mutagenesis
Table 1 Bacterial strains, plasmids and oligonucleotides (Continued)
IM350 (Y369 S
SDM-R)
CTTACGTCACTTACCTTGTTATTAGAGAAAAATAATCTTTGAAGCTTTG
IM490
(Chromosome-F)
ATATCCATGGAAAAGGAGTGTATATAGTGAGAAAAAAACGATATGTATGG NcoI
IM466
(Chromosome-R)
ATATCTGCAGCAAACGTTGCTGTATAGCTATTGG PstI
IM467 (inlA out-F) TATATAGGAAAAATGTGCTGGAACG
IM468 (inlA out-R) TCCTTGATAGTCTACTGCTTGAGTCG
IM317 (inlA muta-F) AAACAGATCTAGACCAAGTTACAACG BglII
IM318 (inlA muta-R) AATTCCACTTCTTTGGTTGTTTCTTTGC BstXI
a Restriction sites are highlighted in bold. Mutated triplets are underlined. The start codon of inlA is in italics.
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struction of the inlA locus was identified by colony PCR
(primers IM317 and IM318) with the integrity of the
gene confirmed by DNA sequencing.
Intragastric versus intravenous infections of Balb/c mice
For all murine experiments, 6-8 week old female Balb/c
mice (Harlan) were used. All experiments were
approved by the institutional ethics committee. Tail vein
intravenous infections were conducted as described pre-
viously [18] with an inoculum comprised of equal num-
bers of EGD-e::pIMC3kan and EGD-e InlA
m* ::
pIMC3ery (2 × 10
4 total in 100 μl). For oral inoculation,
overnight cultures were centrifuged (7,000 × g for 5
min), washed twice with PBS and resuspended at 5 ×
10
10 cfu/ml in PBS containing 100 mg/ml of CaCO3.A
200 μl inoculum was comprised of either a single strain
(5 × 10
9 c f u )o rat w os t r a i nm i x t u r e( 5×1 0
9 of each
strain). Mice were intragrastrically gavaged and the pro-
gression of infection followed over a three day time
course. For bioluminescent imaging, mice were anesthe-
tized on day 1 through to day 3 with isoflurane gas and
imaged in a Xenogen IVIS 100 (Xenogen) at a binning
of 16 for 5 min. Mice were euthanized with spleen and
livers aseptically removed, imaged (binning of 8 for 5
min) and enumerated as previously described [18].
Results
A L. monocytogenes gentamicin protection assay for
murine cells
Invasion into Caco-2 cells by L. monocytogenes is depen-
dent on the expression of functional InlA [10]. We con-
firmed that a L. monocytogenes mutant producing InlA
without the LRR and IR domain (ΔinlA) is severely com-
promised in invasion, while an over expressing InlA strain
exhibits dramatically enhanced invasion (Figure 2). To
establish an equivalent murine assay for L. monocytogenes
we used monolayers of CT-26 cells (murine colonic carci-
noma cell line) originally isolated from Balb/c mice chemi-
cally treated to induce tumor formation [24]. While CT-26
cells are not enterocyte like (they exhibit an undifferen-
tiated-fibroblast appearance [25]), the results from invasion
assays showed that they provide characteristics suitable for
use as an invasion model (Figure 2). The ΔinlA strain dis-
played a slight reduction (not statistically significant) in
invasion compared to EGD-e, while over expression of
InlA resulted in a modest increase in invasion. We specu-
late that this is due to a reduced affinity of InlA for
mCDH1, however we have not assayed for mCDH1 pro-
duction by CT-26 cells.
Heterologous expression was then employed to distin-
guish InlA from additional virulence determinants on the
surface of the L. monocytogenes. We chose to use the well
characterized nisin inducible expression system [26]
(Figure 1) to produce full length InlA on the surface of L.
lactis. The system was chosen because production of func-
tional InlA on the cell surface of L. lactis had previously
been documented [27]. We compared the entry of L. lactis
containing vector only (L. lactis-pNZB), producing wild
type InlA (L. lactis InlA
WT) or producing InlA containing
the Ser192Asn and Tyr369Ser, but with different codon
usage to the previously described murinized InlA
m [17] (L.
lactis InlA
m*) into Caco-2 and CT-26 cells. The presence
of InlA on the cell surface was confirmed by Western blot
analysis (Figure 1b). The level of invasion for L. lactis-
pNZB into Caco-2 cells is similar to that observed for
EGD-eΔinlA (Figure 2 and 3). As L. lactis is non invasive,
the surviving bacterial cells probably represent bacteria
not killed by the gentamicin treatment rather than inter-
nalized cells, as documented previously [1]. A similar level
of entry into Caco-2 cells was observed for L. lactis
InlA
WT and L. lactis InlA
m*, while entry into CT-26 cells
was 27-30 fold greater for L. lactis InlA
m* compared to L.
lactis InlA
WT (Figure 2).
In contrast to a previous report [11], we observed an
increased invasion into a murine cell line by the
L. monocytogenes strain over-expressing InlA
WT in con-
trast to the plasmid only control (Figure 2). A similar
trend was observed when the L. monocytogenes InlA
over-expressing strain and ΔinlA strain were compared
(Figure 2) and was also seen in experiments in the
L. lactis background (Figure 3). These results could be
Figure 2 InlA dependent invasion of EGD-e derrived strains
into human (Caco-2: grey bars) or murine (CT-26: white bars)
monolayers. Exponential phase L. monocytogenes cells (OD = 0.8)
were invaded (MOI of 25:1) in triplicate for 1 h before overlaying
with gentamicin. Invasion was expressed as the average cfu count
per well (with standard deviation) or invasion relative to EGD-e
(below graph) (n = 3). The graph is representative of the data from
three independent experiments.
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Page 6 of 13due to the high level of inlA expression from the Pnis
and Phelp promoters, amplifying the differences in InlA
on the surface of L. lactis and L. monocytogenes cells
(Figure 2 and 3). We interpret these results as evidence
of a specific interaction between InlA and a cell surface
receptor on CT-26 cells which stimulates bacterial cell
entry. To summarise, we have established a gentamicin
protection assay, capable of discriminating InlA
mediated invasion into a murine cell line.
Generation and screening of a random bank of InlA LRR
mutants
To generate diversity within the inlA gene we applied
error prone PCR to the LRR region (between naturally
occurring BglII/BstXI sites - Figure 1a). Four separate
banks were created containing different levels of mutation
frequency, each containing about 40,000 L. lactis clones.
Initial assessment by DNA sequencing of ten clones from
each bank identified mutations throughout the LRR region
with the level of mutation correlating with the concentra-
tion of input template DNA for the error prone PCR (data
not shown). To identify positive mutations, pools were
invaded through CT-26 cells en masse as detailed in Figure
4. Sequential passages through CT-26 cells were required
to remove the background functional InlA from the pools
(Figure 5). Of the four banks only the highest mutation
frequency resulted in an initial recovery below that of wild
type InlA, which suggested that a significant number of
Figure 4 Enrichment protocol for the selection of mutations in
InlA conferring enhanced invasion of L. lactis into CT-26 cells.
Cultures of L. lactis + pNZB containing (i) inlA
WT (ii) inlA
m* or (iii-vi) 4
banks of clones with different levels of mutation in the LRR of
inlA
WT were induced with nisin and assayed for invasion into CT-26
cells by gentamicin protection assay. The residual lysate from
invaded CT-26 cells inoculated into GM17 containing Cm 5 μg/ml
and grown overnight, the culture was then frozen at -80°C. The
entire process was repeated with the frozen stock serving as the
seed for the inoculum.
Figure 5 Enrichment of pools with enhanced invasion into CT-
26 cells. Glycerol stocks from the L. lactis banks (both pre and post
enrichment passages-including controls: InlA
WT and InlA
m*
expressing L. lactis) were incoulated into GM17 media. Nisin
induced cultures were invaded into CT-26 monolayers. Invasion was
expressed relative to L. lactis InlA
WT (set as 100 percent). The graph
is of the data from one experiment.
Figure 3 Invasion of L. lactis expressing wild type or murinized
InlA into Caco-2 (grey bars) or CT-26 (white bars) monolayers.
Nisin induced L. lactis cells were invaded (MOI of 25:1) for 1 h
before overlaying with gentamicin. Invasion was expressed as
average cfu count (with standard deviation) or invasion relative to L.
lactis plasmid only (below graph) (n = 3). The graph is
representative of the data from three independent experiments.
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Page 7 of 13clones contained inactivating mutations. From passage two
through six a significant enrichment in positive mutations
was observed, with a leveling off at passage seven (Figure
5). From passage six, eight clones from each bank were
sequenced (Table 2) and assayed individually using both
CT-26 and Caco-2 cells (Figure 6). All clones exhibited
enhanced entry into CT-26 cells while no apparent differ-
ences for cell entry into Caco-2 cells were observed (com-
pared to L. lactis InlA
WT). However, no clones were
identified which were capable of matching the level of L.
lactis InlA
m* mediated entry into the murine cells.
Sequence analysis revealed that 23 of the 32 clones con-
tained amino acid changes in residues involved in direct
interaction with CDH1. Of the four banks, only the lowest
mutation frequency contained multiple clones with the
same mutation (Gln190Leu), with this single amino acid
change also found in one clone from an additional bank
(Table 2).
Characterization of murinized L. monocytogenes:
competitive index assays
Four inlA sequences conferring enhanced invasion into
CT-26 cells were selected to be re-created in the
chromosome of L. monocytogenes EGD-e. The mutations
constituted two single aa changes for EGD-e A (Asn259-
Tyr) and EGD-e B (Gln190Leu). While three aa changes
were introduced into EGD-e C (T164A, K301I, Q303E)
and EGD-e D (S173I, L185F, L188I). These mutations
were chosen based on the frequency of isolation in
L. lactis (EGD-e B and C), the ability to attribute the
phenotype to an aa change (EGD-e A) and the isolation
of mutations all confined within one LRR (EGD-e D).
A fifth strain was also created based on the Lmo-InlA
m
mutation [18], except with Listeria optimized codons for
192Asn and 369Ser, and was used as a positive control
(EGD-e InlA
m*). Sequencing confirmed the integrity of
the newly introduced mutations, with equivalent levels
of InlA expressed on the surface of the strains as com-
pared to EGD-e (assessed by western blot - data not
shown). InlA
m strain (termed EGD-e InlA
m*) was com-
pared to the parental EGD-e strain for invasion into
Caco-2 and CT-26 monolayers. No differences in inva-
sion (Figure 7a) or adherence (data not shown) were
observed to Caco-2 cells, while the invasion of EGD-e
InlA
m* was significantly higher than EGD-e into CT-26
cells. We then compared the virulence of EGD-e and
Table 2 Supplementary information for Figure 6
Clone 1 2345678
(iii) Low T273I Q190L Q190L Q190L Q190L
T229P
G303E Q190L Q190L
N386I
Fold increase vs Wt 9.44 5.82 6.98 4.15 13.23 12.12 6.10 7.94
(iv) Medium T164A
K301I
G303E
T399I
L86F
N143K
P159A
Q196L
K218M
V224A
G303E
Q306H
Q190L
L329Q
S470C
T164A
K301I
G303E
N259Y
T399I
Q190L
G248R
F193Y
K301E
N413Y
K507I
T164A
K301I
G303E
Fold increase vs Wt 3.25 9.31 7.79 6.85 8.14 6.57 4.05 10.08
(v) High L149M
N259Y
Q190L
S223C
N252Y
I351T
S173I
G303E
T446A
D449H
S173I
T268I
G303E
T446A
D449H
Q190L
S223C
N252Y
I351T
N259Y N239D
S311C
N325D
S173I
L185F
L188I
Fold increase vs Wt 23.21 15.89 8.64 19.31 9.08 16.36 8.24 15.42
(vi) Very High Q190L
A270G
K301G
V123A
Q190L
P290Q
N349D
Q190L Q196K
P290S
L404S
N413Y
D457V
N130I
F150V
L203F
Y369F
N381I
S487N
L294V
S308R
Y369S
N381I
S487N
L122I
S292T
E330V
I458V
Q190L
D199V
S377N
P444S
K495N
Fold increase vs Wt 4.14 9.33 6.96 8.71 9.56 7.12 7.51 9.33
Mutations identified in the BglII/BstXI fragment of pNZBinlA (iii-vi) and the invasion increase into CT-26 cells versus L. lactis InlA
WT. The amino acid mutations
identified which involved in the interaction between InlA
WT and hCDH1 are highlighted in bold.
Details highlighted in bold and italics are mutations recombined in the chromosome of EGD-e.
L. lactis InlA site directed mutants with fold invasion increase into CT-26 cells vs L. lactis InlA
WT in brackets: S192N (21), Y369 S (20), S192N+Y369 S (30).
Below: Amino acids in InlA
WT which interact with hCDH1 and amino acid changes identified from error prone PCR screen. R85, N104: D Q*, N107, F150: V, E170,
E172: T*, Q190: L, S192, R211, D213, I235, T237, E255, N259: Y, K301: I E G, N321: Y, E323, N325: D, E326, Y343, T345, Y347, F348, R365, F367, Y369: F S, W387,
S389. * N104 and E172 mutations were found from additional screens and sequencing.
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m* by competitive index (CI) assays via the
intravenous (i.v.) (Figure 7b) or intragastric (i.g.) (Figure
7c) route in Balb/c mice. For i.v. inoculated mice, no
differences in the kinetics of infection were observed for
either strain (Figure 7b). This confirms that the two
amino acid changes in InlA
m do not impact on the viru-
lence of EGD-e InlA
m* once the gastrointestinal tract is
bypassed. However, EGD-e InlA
m* was significantly
more virulent when infected by the i.g. route, with
higher counts obtained from livers and spleens and a
significantly higher CI value (p < 0.001) for both day
two (Liver 28.9, Spleen 10.6) and day three (Liver 24.9,
Spleen 7.7 - Figure 7c). Neither strain was recovered
form the liver nor spleen at day one post infection. Sub-
sequent competitive index experiments were conducted
by the i.g. route comparing EGD-e InlA
m* against the
strains expressing the InlA mutations identified by the
CT-26 cell screen (Figure 7d). Of the four recreated
strains, only EGD-e A (N259Y) gave a higher CI than
EGD-e in the liver (0.19 vs 0.05) whereas identical
values (0.12) were obtained for the spleens. Further
experimentation will be required to access the
contribution of the N259Y mutation, and it would be
intriguing to see if the recombination of this mutation
into EGD-e InlA
m* would further enhance murine
pathogenicity. It is interesting to note that the strain in
which InlA
m (with Listeria optimized codons for
192Asn and 369Ser) was recreated (EGD-e InlA
m* )d i d
not exhibit enhanced invasion or adhesion to Caco-2
cells, which is a marker for human virulence, in contrast
to the previously published results [17]. To further
explore the progression of i.g. infection, we repeated the
Balb/c inoculations with either EGD-e or EGD-e InlA
m*
tagged with a constitutive bioluminescent lux marker
and mice were imaged for bioluminescence on each
subsequent day [18]. The EGD-e InlA
m* strain exhibited
uniform clinical signs of L. monocytogenes infection by
day 2 [28], while these characteristics were absent from
the EGD-e group even prior to sacrifice at day 3. Con-
sistent with the clinical scores very little light was
observed from the EGD-e group, while increasing light
levels were obtained from the EGD-e InlA
m* group on
days 1 and 2, with a distinct foci evident in the abdo-
men in all 5 mice by day 3 (Figure 8a). Upon ex vivo
imaging of the livers, a low signal was present in the
gall bladder in 3 of the 5 EGD-e infected mice, whereas
a much stronger signal was found from the gall bladders
of all EGD-e InlA
m* (5 out of 5) infected mice, with
infection across the liver also observed (Figure 8a). The
EGD-e InlA
m* infected gall bladders were also found to
be to twice the size of the EGD-e group. Further work
is necessary to determine the exact extent of gall blad-
der colonization in these animals relative to hepatocyte
infection. Enumeration of the livers and spleens con-
firmed that the EGD-e InlA
m* strain produced highly
reproducible i.g. infections, with the levels recovered
comparable to day three i.v. infections in the liver (Fig-
ure 8b). A much larger degree of variation was observed
in the EGD-e group, with statistically significant differ-
ences in bacterial counts observed between the two
strains (Figure 8b). The mechanism of gall bladder colo-
nization is currently unknown [29,30] and warrants
further investigation. The EGD-e InlA
m* strain is cap-
able of establishing highly reproducible colonization of
the gall bladder upon i.g. inoculation. This strain will be
extremely useful in examining factors required for gas-
trointestinal transit and gall bladder colonization.
Discussion
It is now well established that the murine model of lis-
teriosis is limited by a poor interaction between the bac-
terial invasion protein InlA and its host ligand mCDH1.
This is in direct contrast, to the efficient interaction
between InlA and hCDH1. The discrepancy is due to a
glutamate at residue 16 in mouse (and rat) E-cadherin
rendering these host species relatively resistant to
Figure 6 Invasion attributes of individual L. lactis clones post
CT-26 enrichment (passage 6) into Caco-2 (grey bars) or CT-26
(white bars) cells. From each of the four banks, eight clones were
picked and invaded with invasion expressed as the average (with
standard deviation) from triplicate wells. Sequnce data of the clones
is presented in Table 2. Letters above bars indicate sequences that
were subsequently used to recreate into the L. monocytogenes
chromosome. The controls InlA
WT (WT) and InlA
m* (mur) expressing
L. lactis were included for comparison. The graph is of the data
from one experiment.
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Page 9 of 13infection by the oral route and limiting their use as
laboratory models for certain L. monocytogenes-mediated
disease processes [11]. Recent studies have developed an
engineered mouse strain expressing ‘humanized’ E-cad-
herin for studies of oral and fetoplacental listeriosis [14].
An alternative approach has utilized structure-based
engineering to ‘murinize’ the bacterial InlA protein in
order to increase affinity for murine E-cadherin [17].
This approach has provided key insights into the inter-
action between InlA and CDH1. While murinization
was highly successful, we reasoned that additional points
of contact may also improve the interaction with
mCDH1. We therefore developed a system to select ran-
dom mutations in InlA that enhance invasion of murine
cells in order to identify novel amino acid interactions
and to determine if ‘murinization’ of the strain can be
improved.
L. lactis was used as a surrogate host for this process in
order to prevent generation of Listeria mutants with
increased affinity for human cells. Previous research had
shown that heterologous expression of InlA from the
native PinlA promoter in L. lactis could stimulate invasion
into cultured human colonic enterocytes and guinea pig
enterocytes in an oral infection model [27]. Additional
properties of L. lactis such as high transformation effi-
ciency (4 × 10
4 cfu for ligations) allowed us to generate
multiple random libraries of substantial size and enabled
the direct transformation of SDM constructs. Also the
nisin inducible system enabled a high level of InlA expres-
sion on the surface of L. lactis in a background with rela-
tively few sortase A anchored proteins.
The ability of L. lactis InlA
m* to facilitate uptake into
murine cells encouraged us to use multiple rounds of en
masse enrichment of InlA mutant libraries through CT-
26 cells. The cumulative results from each passage
showed a continued improvement in the invasion effi-
ciency, suggestive of an enrichment of positive clones. A
surprising level of diversity in InlA clones was apparent
(across the 4 banks) with 25 of the 32 clones analyzed
exhibiting unique sequences. Only bank iii with the low-
est frequency of mutations exhibited a degree of clonal-
ity (4/8 were Q190L). This suggests that we have not
Figure 7 Recretion of selected InlA mutations in EGD-e. A. Comparison of the invasion attributes of EGD-e and EGD-e InlA
m* (Ser192Asn/
Trp369Ser). Exponential phase L. monocytogenes cells (OD = 0.8) were invaded (MOI of 25:1) in triplicate for 1 h before overlaying with
gentamicin. Invasion was expressed as the average cfu count per well (with standard deviation) or invasion relative to EGD-e (below graph). The
graph is representative of the data from three independent experiments. B. The relative virulence of EGD-e compared against EGD-e InlA
m*
(tagged with pIMC3kan and pIMC3ery respectively) was accessed by competitive index after i.v. infection (1 × 10
4 cfu of each strain) of 15 Balb/c
mice. On each subsequent day 5 mice were euthanized and spleens and livers aseptically removed and enumerated. Data are presented as the
mean and standard deviation of 5 mice, competitive indices and statistical analysis was conducted using the one sample t test as described
previously [18]. NS = Not significant. C. Oral inoculations of Balb/c mice with EGD-e::pIMC3kan and EGD-e InlA
m* ::pIMCery mixed at a 1:1 ratio in
a total inoculum of 1 × 10
10 cfu/200 μl containing 100 mg of CaCO3. *** = p < 0.005. D. Competitive index virulence in a Balb/c oral infection
model with EGD-e InlA
m* ::pIMC3ery competed against EGD-e::pIMC3kan, EGD-e A::pIMC3kan (InlA-N259Y), EGD-e B::pIMC3kan (InlA-Q190L), EGD-
e C::pIMC3kan (InlA-T164A/K301I/G303E) or EGD-e D::pIMC3kan (InlA-S173I/L185F/L188I) as described in C. The invasion levels were significantly
(p < 0.005) different than EGD-e InlA
m* for all competed strains.
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the banks which confer enhanced invasion capabilities.
Directed evolution of the inlA gene has the potential
to uncover mutations not predicted by a structure-based
approach (Table 2). With respect to the Q190L muta-
tion the glutamine at residue 190 found on LRR 6
within the hydrophobic pocket, and forms a hydrogen
bond to proline 16 in hCDH1. The change to leucine
may affect the pocket and improve access of glutamic
acid 16 in mCDH1. Of all the single amino acid
changes, the N259Y mutation exhibited the single great-
est invasion increase into CT-26 cells. Combining this
mutation with either T399I or L149 M was shown to
reduce or enhance invasion, respectively, with the nega-
tive effect of the T399I confirmed by the reduction in
invasion efficiency observed when combined with addi-
tional positive mutations (bank IV, clone 8 versus bank
IV, clone 1-Table 2). Further biochemical studies will be
required to identify the role these mutations play to
enhance the interaction with mCDH1. The previously
identified single aa changes at residues 192 and 369 [17]
each increased invasion ~20 fold, whereas the combined
192 + 369 mutations increased invasion ~30 fold. The
identical aa change at residue 369 was also isolated from
our error prone PCR bank. However, this clone con-
tained additional mutations that resulted in a reduced
level of invasion compared to the 369 single mutant.
The CDH1 interacting amino acids appear to be
highly conserved and recalcitrant to change [31]. From a
collection of 101 inlA gene sequences mapped onto the
InlA crystal structure [32], three naturally occurring
InlA variants were identified which could potentially
mediate an interaction with hCDH1, with one (Lys301-
Glu) also identified throught h er a n d o mm u t a g e n e s i s
approach in our study. However, while all mutants con-
taining this residue had a positive effect on invasion into
CT-26 cells, the exact contribution of this residue could
not be assessed as additional mutations were present in
all clones. Further analysis of individual clones from
each bank or the application of additional selection is
required due to the diversity uncovered (25 of the 32
clones analyzed were different). This diversity and the
enhanced invasion of all the clones examined confirms
that amino acids additional to the ones previously exam-
ined [17] can modulate the affinity for CDH1.
Despite the analysis of 32 clones from our enriched
bank of InlA variants, we failed to detect mutations that
yielded invasion rates comparable to the murinized InlA
described by Wollert and coworkers [17]. In terms of
developing usable models of murine listeriosis the
approach of ‘murinizing’ the bacterial strain arguably
has a number of benefits over the development of
humanized mouse lines. Development of the modified
bacterium will permit utilization of this strain in existing
mouse lines (including existing knock-out murine mod-
els) and distribution of the murinized strain is relatively
straightforward, as is the creation of new mutations in
the EGD-e InlA
m* background. However, the 2-fold
enhanced adherence and invasion to human (Caco-2)
cells of the L. monocytogenes Lmo-InlA
m [17] could be a
potential cause for concern as it is suggestive of a slight
enhancement of virulence towards humans. The proce-
dure used to create that strain required multiple pro-
longed incubations at 42°C [17,33]. It has been recently
shown that high temperature growth of L. monocyto-
genes can induce spontaneous mutation, suggesting that
high temperature growth should be minimized to avoid
the acquisition of secondary mutations [34]. We re-cre-
ated the InlA mutations described by Wollert et al., [17]
to create EGD-e InlA
m* using only two temperature
shifts to 37°C and six passages under non-selective
Figure 8 Bioluminescent imaging (BLI) of Balb/c mice orally
infected with either EGD-e or EGD-e InlA
m* (tagged with
pIMK2lux). A. Balb/c mice (five per group) were gavaged with a
total of 5 × 10
9 cfu and the progression of infection in each mouse
(labelled 1 thru 5) followed on day one, two and three by BLI.
Pseudocolor overlay represents the light emission profile from the
infected mice with the scale bar on the right hand side. On day
three mice were euthanized and livers examined ex vivo by BLI.
B. Total bacterial loads from livers and spleens were numbered. The
cross line denotes the mean organ cfu recovery for the five mice.
Statistical analysis was conducted using a student t test with the
p-value shown on the graph.
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InlA
m and EGD-e InlA
m* strain were the nucleotide
changes made to create the mutated amino acids. In the
EGD-e InlA
m* strain the two codons were chosen based
on the codon usage from genome analysis, with the
most commonly used triplets applied. In each case
usage was 50% higher than the one used in Lmo-InlA
m.
For the asparagine 192, AAT compared to the AAC
codon was chosen (31.8 vs 14.4 per 1000 codons).
While for serine 369 TCT compared to TCG codon was
chosen (12.8 vs 6.2 per 1000 codons). The invasion data
for Lmo-InlA
m agreed with the biophysical characteriza-
tion which showed an enhanced interaction for InlA
with CDH1 [35] however as recently shown, synon-
ymous mutations leading to mRNA sequence changes
can also affect substrate specificity or protein activity
[36]. To access the role of codon usage or strain back-
ground, competitive index experiments will need to be
conducted to directly compare Lmo-InlA
m with EGD-e
InlA
m*.
Conclusions
The research presented here generated random InlA
variants with enhanced invasion into the CT-26 cell line
most likely through an increased affinity for mCDH1.
Novel mutations in InlA were readily identified from the
random mutagenesis approach and a number (including
the N259Y mutation) are worthy of further study. The
approach used here indicates that other random or tar-
geted mutagenesis strategies may uncover mutations
that further enhance protein-ligand binding. In particu-
lar we suggest that screening approaches such as bio-
panning [37] using the first extra cellular domain of
mCDH1 as bait or a site-saturation mutagenesis
approach (the analysis of all amino acid combinations at
as i n g l er e s i d u e )[ 3 8 ]m a yu n c o v e rf u r t h e rp o t e n t i a l
interactions. We have demonstrated that the newly cre-
ated strain, EGD-e InlA
m* does not have an enhanced
affinity for human cells (unlike the predecessor EGD-
InlA
m) while displaying highly reproducible oral infec-
tions in the mouse model. The use of this murinized L.
monocytogenes strain will prove a useful tool in analys-
ing the gastrointestinal phase of listeriosis. The addi-
tional residues identified here as playing a role in InlA::
CDH1 interactions will inform our ongoing efforts to
create safer ‘murinised’ versions of L. monocytogenes
which will help us to combat this often fatal pathogen.
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